RPG
AZN icon

Risk Paradigm Group’s AstraZeneca AZN Stock Holding History

Risk Paradigm Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,100
Closed -$76.9K – 101
2018
Q1 		$76.9K Hold
1,100
– – 0.1% 127
2017
Q4 		$76.3K Hold
1,100
– – 0.08% 134
2017
Q3 		$74.5K Sell
1,100
-280
-20% -$17.7K 0.09% 124
2017
Q2 		$94.1K Hold
1,380
– – 0.11% 118
2017
Q1 		$85.9K Buy
1,380
+150
+12% +$8.73K 0.1% 112
2016
Q4 		$67.2K Buy
1,230
+50
+4% +$2.84K 0.07% 147
2016
Q3 		$77.5K Buy
1,180
+100
+9% +$6.54K 0.06% 146
2016
Q2 		$65.2K Buy
1,080
+50
+5% +$2.9K 0.09% 139
2016
Q1 		$58K Sell
1,030
-947
-48% -$56.9K 0.07% 131
2015
Q4 		$134K Buy
1,977
+667
+51% +$43.7K 0.16% 83
2015
Q3 		$83.3K Buy
1,310
+280
+27% +$18.4K 0.17% 70
2015
Q2 		$65.6K Buy
1,030
+200
+24% +$13.7K 0.06% 108
2015
Q1 		$56.8K Buy
+830
New +$57.7K 0.06% 110

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Risk Paradigm Group's AZN Position: Q2 2018 in Review

Risk Paradigm Group sold out of AstraZeneca (AZN) in Q2 2018, closing a stake of 1,100 shares — an estimated $76.9K sold.

Risk Paradigm Group first reported a position in AZN in Q1 2015 and held it in 13 quarters. The position peaked at $134K in Q4 2015. 530 funds tracked by Wall St. Rank hold AZN as of Q2 2018.

  • Risk Paradigm Group reported no remaining AstraZeneca position as of Q2 2018 after selling out during the quarter.
  • Risk Paradigm Group sold 1,100 AstraZeneca shares in Q2 2018, an estimated $76.9K.
  • Risk Paradigm Group first reported a position in AstraZeneca in Q1 2015 and held it in 13 quarters.
  • Risk Paradigm Group's AstraZeneca position peaked at $134K in Q4 2015.
  • 530 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2018.

Based on Risk Paradigm Group's 13F filing for Q2 2018, filed 10 Aug 2018.